Opinion

Video

Challenges of Concurrent Administration: RSV and Other Vaccines

The panelists address the challenges of administering multiple vaccines to eligible patients, while also discussing the timing and compatibility of administering certain vaccines simultaneously. They emphasize the importance of being receptive to patient concerns and providing guidance on childhood vaccinations for hesitant individuals.

Related Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Related Content
Air purifier in cozy white bedroom for filter and cleaning removing dust PM2.5 HEPA in home,for fresh air and healthy life,Air Pollution Concept - Image credit: 220 Selfmade studio | stock.adobe.com
November 19th 2024

Study: In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia, Assistant Editor
MEDcast logo
July 1st 2024

Key Considerations for the Effective Utilization of RSV Vaccines

Ashley Pugh, PharmD, BCACP Lauren B. Angelo, PharmD, MBA
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
November 13th 2024

RSV Vaccine Displays Effectiveness Against RSV-Associated Hospitalizations

Kennedy Ferruggia, Assistant Editor
Vaccine bottles and syringes for preventing respiratory syncytial virus(RSV) - Image credit: kitsawet | stock.adobe.com
November 7th 2024

Researchers Highlight Need for Increased RSV Vaccination

Kennedy Ferruggia, Assistant Editor
Bottles of vaccine for Influenza Virus, Respiratory Syncytial virus and Covid-19 for vaccination. Flu, RSV and Sars-cov-2 Coronavirus vaccine vials in the medical clinic - Image credit: angellodeco | stock.adobe.com
October 30th 2024

Public Concern of RSV Infection Has Decreased as Flu and COVID-19 Remain a Worry

Kennedy Ferruggia, Assistant Editor
Vaccine bottles and syringes for preventing respiratory syncytial virus (RSV) - Image credit: kitsawet | stock.adobe.com
October 23rd 2024

FDA Approves Abrysvo to Treat Adults 18 to 59 Years of Age at Increased Risk for RSV

Kennedy Ferruggia, Assistant Editor